Conference Coverage
Conference Coverage
Advanced HF no obstacle to AFib ablation success: CASTLE-HTx
One of the study’s key messages “is that AF ablation is safe and effective in patients with end-stage heart failure” and “should be part of our...
Conference Coverage
More weight loss linked with more benefit in STEP-HFpEF
“The outcomes we’ve already seen in STEP-HFpEF were largely symptomatic, which are extraordinarily important, but there may be a completely...
Conference Coverage
IV iron shows only modest benefit in HF: HEART-FID
It was hoped that the study would confirm benefits suggested in previous smaller studies, but its modest results seem to have caused more...
Conference Coverage
Traditional Chinese medicine improves outcomes in HFrEF
The ESC-invited discussant called the outcome “remarkable” and a validation for “the millions of people” who are already taking qiliqiangxin in...
Conference Coverage
Anticoagulation no benefit in presumed AFib detected by cardiac devices
“Based on the result of this trial, these occasional atrial high-rate episodes do not appear to be associated with stroke. It appears quite benign...
Conference Coverage
Cardiac arrest centers no benefit in OHCA without STEMI
On the other hand, patients with MI “will benefit from going straight to a heart attack center and having an attempt at reopening the artery.”
Conference Coverage
No reduction in AFib after noncardiac surgery with colchicine: COP-AF
“We think that further studies are needed to tease out which patients can benefit from colchicine and in what setting it can be used.”
Conference Coverage
ESC issues new guidelines on infective endocarditis
Diagnosing a lethal, rare, but not uncommon disease such as endocarditis “is something that clinicians struggle with every day,” he noted,...
Conference Coverage
FIRE a win for physiology-guided MI complete revascularization in older patients
"This is the first trial actually showing a benefit" from physiology-guided CR in older patients with acute MI that is similar to what the...
Conference Coverage
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
Another major change in the new ESC guideline revision is introduction of a CVD risk calculator intended to estimate the risk among people with...
Conference Coverage
Acoramidis shows encouraging results in ATTR cardiomyopathy
“ATTRibute-CM was a robustly positive trial, showing benefits across the board for acoramidis, and suggest the tantalizing possibility of genuine...